ImmunoACT
Blood & Organ Banks · India · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Immunoact 1st floor r-977 T.t.c. Industr...Website
www.immunoact.comRevenue
<$5 MillionIndustry
About ImmunoACT
ImmunoACT specializes in CAR-T cell therapy, providing advanced treatment options for blood cancers such as lymphoma and leukemia in India. The company focuses on making innovative cancer therapies accessible and affordable, utilizing indigenous technology to enhance patient outcomes. With a commitment to expanding access to transformative care, ImmunoACT collaborates with over 80 leading cancer treatment hospitals and partners internationally to improve cancer care. Their proprietary NexCAR19 therapy has shown significant success in patient remission rates, positioning ImmunoACT as a leader in the field of immunotherapy.Explore more
ImmunoACT Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
ImmunoACT Tech Stack
A closer look at the technologies used by ImmunoACT
Top Blood & Organ Banks Companies
See more top companies
Frequently Asked Questions Regarding ImmunoACT
Sign Up For FreeTo access detailed company insights
ImmunoACT specializes in CAR-T cell therapy, providing advanced treatment options for blood cancers such as lymphoma and leukemia in India. The company focuses on making innovative cancer therapies accessible and affordable, utilizing indigenous technology to enhance patient outcomes. With a commitment to expanding access to transformative care, Im... Read More
